Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "User talk:Beno Marija/MitO2 MitoPedia"

From Bioblast
Line 1: Line 1:
{{MitoPedia
{{MitoPedia
|abbr=MitO2
|abbr=Mit-CII
|description='''Cell permeable prodrug''', composed of [[NV1641]] and [[NV118]], of the complex II substrate succinate increase ATP-linked mitochondrial respiration in CI-deficient human blood cells, fibroblasts and heart fibres.
|description='''Cell permeable prodrug''', composed of [[NV1641]] and [[NV118]], of the complex II substrate succinate increase ATP-linked mitochondrial respiration in CI-deficient human blood cells, fibroblasts and heart fibres.
|info=[[MitO2-Kit]], [[Ehinger 2016 Nat Commun]]
|info=[[Mit-CII-Kit]], [[Ehinger 2016 Nat Commun]]
}}
}}
{{MitoPedia topics
{{MitoPedia topics
|mitopedia topic=Medium
|mitopedia topic=Medium
}}
}}
* For preparation of MitO2, see [[MitO2-Kit]].
* For preparation of Mit-CII, see [[Mit-CII-Kit]].

Revision as of 16:17, 19 March 2019


high-resolution terminology - matching measurements at high-resolution


User talk:Beno Marija/MitO2 MitoPedia

Description

Cell permeable prodrug, composed of NV1641 and NV118, of the complex II substrate succinate increase ATP-linked mitochondrial respiration in CI-deficient human blood cells, fibroblasts and heart fibres.

Abbreviation: Mit-CII

Reference: Mit-CII-Kit, Ehinger 2016 Nat Commun


MitoPedia topics: Media for respirometry